相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cyclin dependent kinase (CDK) inhibitors as anticancer drugs
Concepcion Sanchez-Martinez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
p53 orchestrates calcium signaling in vivo
Giovanni Sorrentino et al.
CELL CYCLE (2015)
The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2
Oluwafunmilayo F. Lamidi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Peloruside A Inhibits Growth of Human Lung and Breast Tumor Xenografts in an Athymic nu/nu Mouse Model
Colin J. Meyer et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Aneuploidy and chromosomal instability in cancer: a jackpot to chaos
Maybelline Giam et al.
CELL DIVISION (2015)
Folate-Vinca Alkaloid Conjugates for Cancer Therapy: A Structure-Activity Relationship
Christopher P. Leamon et al.
BIOCONJUGATE CHEMISTRY (2014)
Tubulin inhibitors: a patent review
Yi-Min Liu et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
17-Beta-Estradiol Analog Inhibits Cell Proliferation by Induction of Apoptosis in Breast Cell Lines
Michelle Helen Visagie et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2014)
Evaluation of 2′,4′-dihydroxy-3,4,5-trimethoxychalcone as antimitotic agent that induces mitotic catastrophe in MCF-7 breast cancer cells
Kamonporn Masawang et al.
TOXICOLOGY LETTERS (2014)
NOVEL ESTRADIOL ANALOGUE INDUCES APOPTOSIS AND AUTOPHAGY IN ESOPHAGEAL CARCINOMA CELLS
Elize Wolmarans et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2014)
Molecular aspects of cancer cell resistance to chemotherapy
Magali Rebucci et al.
BIOCHEMICAL PHARMACOLOGY (2013)
MicroRNAs: Novel mediators of resistance to microtubule-targeting agents
Arun Kanakkanthara et al.
CANCER TREATMENT REVIEWS (2013)
PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
R. Wendel Naumann et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Synthesis and Biological Activity of 3-N-Substituted Estrogen Derivatives as Breast Cancer Agents
Zhongliang Wan et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis
R. A. Veldhoen et al.
ONCOGENE (2013)
Signaling Pathways of ESE-16, an Antimitotic and Anticarbonic Anhydrase Estradiol Analog, in Breast Cancer Cells
Barend Andre Stander et al.
PLOS ONE (2013)
Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B
Aneta Rogalska et al.
TOXICOLOGY IN VITRO (2013)
Nanoparticle and targeted systems for cancer therapy
Lisa Brannon-Peppas et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1
X. L. Dong et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
Cabazitaxel: More Than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2012)
Eribulin-A review of preclinical and clinical studies
Umang Swami et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Minireview: G Protein-Coupled Estrogen Receptor-1, GPER-1: Its Mechanism of Action and Role in Female Reproductive Cancer, Renal and Vascular Physiology
Edward J. Filardo et al.
ENDOCRINOLOGY (2012)
US Food and Drug Administration Approval Overview in Metastatic Breast Cancer
Patricia Cortazar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Multicenter Trial of EC145 in Advanced, Folate-Receptor Positive Adenocarcinoma of the Lung
Martin J. Edelman et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
The proliferation rate paradox in antimitotic chemotherapy
Timothy J. Mitchison
MOLECULAR BIOLOGY OF THE CELL (2012)
βII-Tubulin and βIII-Tubulin Mediate Sensitivity to Peloruside A and Laulimalide, but not Paclitaxel or Vinblastine, in Human Ovarian Carcinoma Cells
Arun Kanakkanthara et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression
Stefania Nobili et al.
MEDICINAL RESEARCH REVIEWS (2012)
Review of hormonal treatment of breast cancer
I. H. Abdulkareem et al.
NIGERIAN JOURNAL OF CLINICAL PRACTICE (2012)
The European Medicines Agency Review of Cabazitaxel (Jevtana®) for the Treatment of Hormone-Refractory Metastatic Prostate Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
Elias Pean et al.
ONCOLOGIST (2012)
In Vitro Evaluation of ESE-15-ol, an Estradiol Analogue with Nanomolar Antimitotic and Carbonic Anhydrase Inhibitory Activity
Barend Andre Stander et al.
PLOS ONE (2012)
Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance
Feihu Wang et al.
BIOMATERIALS (2011)
Cooperative Phosphorylation of FADD by Aur-A and Plk1 in Response to Taxol Triggers Both Apoptotic and Necrotic Cell Death
Moon-Sun Jang et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
P. N. Kelly et al.
CELL DEATH AND DIFFERENTIATION (2011)
Docking, Synthesis, and in vitro Evaluation of Antimitotic Estrone Analogs
Andre Stander et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
Ravi K. Amaravadi et al.
CLINICAL CANCER RESEARCH (2011)
Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion
Hye-Jin Shin et al.
JOURNAL OF CELL SCIENCE (2011)
Recent Developments in Cancer Vaccines
Karolina Palucka et al.
JOURNAL OF IMMUNOLOGY (2011)
Ixabepilone, a Novel Microtubule-Targeting Agent for Breast Cancer, Is a Substrate for P-Glycoprotein (P-gp/MDR1/ABCB1) but not Breast Cancer Resistance Protein (BCRP/ABCG2)
H. Shen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
Ming Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Multiple Drug Resistance Mechanisms in Cancer
Bruce C. Baguley
MOLECULAR BIOTECHNOLOGY (2010)
Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
Philippe L. Bedard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
Separase Is Recruited to Mitotic Chromosomes to Dissolve Sister Chromatid Cohesion in a DNA-Dependent Manner
Yuxiao Sun et al.
CELL (2009)
Tumor Self-Seeding by Circulating Cancer Cells
Mi-Young Kim et al.
CELL (2009)
Cancer cell apoptotic pathways mediated by PEDF: prospects for therapy
Matthew L. Broadhead et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Cardiac toxicity in breast cancer survivors: Review of potential cardiac problems
Brian R. J. Healey Bird et al.
CLINICAL CANCER RESEARCH (2008)
Linking kinetochore-microtubule binding to the spindle checkpoint
Daniel J. Burke et al.
DEVELOPMENTAL CELL (2008)
How do microtubule-targeted drugs work? An overview
Mary Ann Jordan et al.
CURRENT CANCER DRUG TARGETS (2007)
The spindle-assembly checkpoint in space and time
Andrea Musacchio et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Targeting tumor-associated carbonic anhydrase IX in cancer therapy
Anne Thiry et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1
In Hwa Bae et al.
CANCER RESEARCH (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
β-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells
Y Gökmen-Polar et al.
CANCER RESEARCH (2005)
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay
N Parker et al.
ANALYTICAL BIOCHEMISTRY (2005)
What's wrong with our cancer models?
A Kamb
NATURE REVIEWS DRUG DISCOVERY (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
RBG Ravelli et al.
NATURE (2004)
Peloruside A does not bind to the taxoid site on β-tubulin and retains its activity in multidrug-resistant cell lines
TN Gaitanos et al.
CANCER RESEARCH (2004)
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs
TM Ganten et al.
CELL DEATH AND DIFFERENTIATION (2004)
Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography
Z Cruz-Monserrate et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Measuring the side effects of taxane therapy in oncology - The functional assessment of cancer therapy-taxane (FACT-taxane)
D Cella et al.
CANCER (2003)
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
NJ Mabjeesh et al.
CANCER CELL (2003)
AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol
S Anand et al.
CANCER CELL (2003)
Mad2 and BubR1 function in a single checkpoint pathway that responds to a loss of tension
KB Shannon et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity
DE Pryor et al.
BIOCHEMISTRY (2002)
Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1
A Hagting et al.
JOURNAL OF CELL BIOLOGY (2002)
Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2
V Sudakin et al.
JOURNAL OF CELL BIOLOGY (2001)
Microtubule-stabilizing agents: a growing class of important anticancer drugs
KH Altmann
CURRENT OPINION IN CHEMICAL BIOLOGY (2001)
Spindle checkpoint protein Bub1 is required for kinetochore localization of Mad1, Mad2, Bub3, and CENP-E, independently of its kinase activity
H Sharp-Baker et al.
JOURNAL OF CELL BIOLOGY (2001)
Expression of hypoxia-lnducible cell-surface transmembrane carbonic anhydrases in human cancer
S Ivanov et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Control of mitosis by changes in the subcellular location of cyclin-B1-Cdkw and Cdc25C
CG Takizawa et al.
CURRENT OPINION IN CELL BIOLOGY (2000)
分享论文
